참고문헌 (115)

1. Trépo C. Chan H. L. Lok A. Hepatitis B virus infection Lancet 2014 384 9959 2053 2063 10.1016/S0140-6736(14)60220-8 24954675 

   상세보기

2. Zuckerman J. N. Protective efficacy, immunotherapeutic potential and safety of hepatitis B vaccines J. Med. Virol. 2006 78 169 177 10.1002/jmv.20524 16372285 

   상세보기

3. Bartholomeusz A. Locarnini S. Hepatitis B virus mutations associated with antiviral therapy J. Med. Virol. 2006 78 1 S52 S55 10.1002/jmv.20608 16622878 

   상세보기

4. Budzinska M. A. Shackel N. A. Urban S. et al. , Cellular Genomic Sites of Hepatitis B Virus DNA Integration Genes 2018 9 7 E365 10.3390/genes9070365 30037029 

   상세보기

5. Zhang J. Zong L. Wang Y. et al. , Core gene insertion in hepatitis B virus genotype G functions at both the encoded amino acid sequence and RNA structure levels to stimulate core protein expression Virology 2019 526 203 213 10.1016/j.virol.2018.11.002 30415131 

   상세보기

6. Huang J. Zhang K. Chen W. et al. , Switching to PegIFNα-2b leads to HBsAg loss in patients with low HBsAg levels and HBV DNA suppressed by NAs Sci. Rep. 2017 7 1 13383 10.1038/s41598-017-13747-9 29042662 

   상세보기

7. Mu D. Yuan F. C. Chen Y. et al. , Baseline value of intrahepatic HBV DNA over cccDNA predicts patient's response to interferon therapy Sci. Rep. 2017 7 1 5937 10.1038/s41598-017-05242-y 28725013 

   상세보기

8. Zhu H. P. Gu Y. R. Zhang G. L. et al. , Depression in patients with chronic hepatitis B and cirrhosis is closely associated with the severity of liver cirrhosis Exp. Ther. Med. 2016 12 405 409 10.3892/etm.2016.3271 27347069 

   상세보기

9. Cornberg M. Jaroszewicz J. Manns M. P. et al. , Treatment of chronic hepatitis B Minerva Dietol. Gastroenterol. 2010 56 451 465 

10. Scotti L. Scotti M. T. Multi-Target Drugs Against Metabolic Disorders Endocr., Metab. Immune Disord.: Drug Targets 2019 19 4 389 390 10.2174/187153031904190506102405 31274061 

    상세보기

11. Chen L. Wang X. Liu Y. et al. , Dual-target screening of bioactive components from traditional Chinese medicines by hollow fiber-based ligand fishing combined with liquid chromatography-mass spectrometry J. Pharm. Biomed. Anal. 2017 5 143 269 276 10.1016/j.jpba.2017.06.001 

    상세보기

12. Liu W. Liu Y. Youyou Tu: significance of winning the 2015 Nobel Prize in Physiology or Medicine Cardiovasc. Diagn. Ther. 2016 6 1 1 2 10.1016/j.jpba.2016.04.027 26885485 

    상세보기

13. Cho J. Y. Nam K. H. Kim A. R. et al. , In vitro and in vivo immunomodulatory effects of syringin J. Pharm. Pharmacol. 2001 53 9 1287 1294 10.1211/0022357011776577 11578112 

    상세보기

14. Kim B. Kim M. S. Hyun C. K. Syringin attenuates insulin resistance via adiponectin-mediated suppression of low-grade chronic inflammation and ER stress in high-fat diet-fed mice Biochem. Biophys. Res. Commun. 2017 488 1 40 45 10.1016/j.bbrc.2017.05.003 28476623 

    상세보기

15. Niu H. S. Liu I. M. Cheng J. T. et al. , Hypoglycemic effect of syringin from Eleutherococcussenticosus in streptozotocin-induced diabetic rats Planta Med. 2008 74 2 109 113 10.1055/s-2008-1034275 18203055 

    상세보기

16. Liu K. Y. Wu Y. C. Liu I. M. et al. , Release of acetylcholine by syringin, an active principle of Eleutherococcus senticosus, to raise insulin secretion in Wistar rats Neurosci. Lett. 2008 434 2 195 199 10.1016/j.neulet.2008.01.054 18304730 

    상세보기

17. Liu J. Zhang Z. Guo Q. et al. , Syringin prevents bone loss in ovariectomized mice via TRAF6 mediated inhibition of NF-κB and stimulation of PI3K/AKT Phytomedicine 2018 15 42 43 50 

18. Song Y. Y. Li Y. Zhang H. Q. Therapeutic effect of syringin on adjuvant arthritis in rats and its mechanisms Yaoxue Xuebao 2010 45 8 1006 1011 

    상세보기

19. Cui Y. Zhang Y. Liu G. Syringin may exert sleep-potentiating effects through the NOS/NO pathway Fundam. Clin. Pharmacol. 2015 29 2 178 184 10.1111/fcp.12095 25377727 

    상세보기

20. Li F. Zhang N. Wu Q. et al. , Syringin prevents cardiac hypertrophy induced by pressure overload through the attenuation of autophagy Int. J. Mol. Med. 2017 39 1 199 207 10.3892/ijm.2016.2824 27959392 

    상세보기

21. Zhang A. Liu Z. Sheng L. et al. , Protective effects of syringin against lipopolysaccharide-induced acute lung injury in mice J. Surg. Res. 2017 209 252 257 10.1016/j.jss.2016.10.027 28032567 

    상세보기

22. Yang E. J. Kim S. I. Ku H. Y. et al. , Syringin from stem bark of Fraxinus rhynchophylla protects Abeta(25-35)-induced toxicity in neuronal cells Arch. Pharmacal Res. 2010 33 4 531 538 10.1007/s12272-010-0406-z 

    원문보기 상세보기

23. Gong X. Zhang L. Jiang R. et al. , Hepatoprotective effects of syringin on fulminant hepatic failure induced by D-galactosamine and lipopolysaccharide in mice J. Appl. Toxicol. 2014 34 3 265 271 10.1002/jat.2876 23620140 

    상세보기

24. Wang X. Zhang A. Yan G. et al. , Metabolomics and proteomics annotate therapeutic properties of geniposide: targeting and regulating multiple perturbed pathways PLoS One 2013 8 8 e71403 10.1371/journal.pone.0071403 23967205 

    상세보기

25. Graham E. B. Crump A. R. Kennedy D. W. et al. , Multi 'omics comparison reveals metabolome biochemistry, not microbiome composition or gene expression, corresponds to elevated biogeochemical function in the hyporheic zone Sci. Total Environ. 2018 642 742 753 10.1016/j.scitotenv.2018.05.256 29920461 

    상세보기

26. Zhang A. Sun H. Wang P. et al. , Metabonomics for discovering biomarkers of hepatotoxicity and nephrotoxicity Die Pharmazie 2012 67 2 99 105 22512077 

27. Mizuno H. Ueda K. Kobayashi Y. et al. , The great importance of normalization of LC-MS data for highly-accurate non-targeted metabolomics Biomed. Chromatogr. 2017 31 1 e3864 10.1002/bmc.3864 27718276 

    상세보기

28. Wang X. Lv H. Zhang A. et al. , Metabolite profiling and pathway analysis of acute hepatitis rats by UPLC-ESI MS combined with pattern recognition methods Liver Int. 2014 34 5 759 770 10.1111/liv.12301 24004042 

    상세보기

29. Ribbenstedt A. Ziarrusta H. Benskin J. P. Development, characterization and comparisons of targeted and non-targeted metabolomicsmethods PLoS One 2018 13 11 e0207082 10.1371/journal.pone.0207082 30439966 

    상세보기

30. Zhang A. Sun H. Yan G. et al. , Urinary metabolic profiling identifies a key role for glycocholic acid in human liver cancer by ultra-performance liquid-chromatography coupled with high-definition mass spectrometry Clin. Chim. Acta 2013 418 86 90 10.1016/j.cca.2012.12.024 23313056 

    상세보기

31. Wang X. Wang Q. Zhang A. et al. , Metabolomics study of intervention effects of Wen-Xin-Formula using ultra high-performance liquid chromatography/mass spectrometry coupled with pattern recognition approach J. Pharm. Biomed. Anal. 2013 74 22 30 10.1016/j.jpba.2012.10.009 23245229 

    상세보기

32. Zhang A. Sun H. Wang X. Urinary metabolic profiling of rat models revealed protective function of scoparone against alcohol induced hepatotoxicity Sci. Rep. 2014 4 6768 10.1038/srep06768 25341677 

    상세보기

33. Nan Y. Zhou X. Liu Q. et al. , Serum metabolomics strategy for understanding pharmacological effects of ShenQi pill acting on kidney yang deficiency syndrome J. Chromatogr. B: Anal. Technol. Biomed. Life Sci. 2016 1026 217 226 10.1016/j.jchromb.2015.12.004 26747643 

    상세보기

34. Li X. N. Zhang A. Wang M. et al. , Screening the active compounds of Phellodendri Amurensis cortex for treating prostate cancer by high-throughput chinmedomics Sci. Rep. 2017 7 46234 10.1038/srep46234 28383015 

    상세보기

35. Zhang A. Sun H. Han Y. et al. , Urinary metabolic biomarker and pathway study of hepatitis B virus infected patients based on UPLC-MS system PLoS One 2013 8 5 e64381 10.1371/journal.pone.0064381 23696887 

    상세보기

36. Sun H. Zhang A. H. Song Q. et al. , Functional metabolomics discover pentose and glucuronate interconversion pathways as promising targets for Yang Huang syndrome treatment with Yinchenhao Tang RSC Adv. 2018 8 36831 36839 10.1039/C8RA06553E 

    상세보기

37. Zhao Y. Lv H. Qiu S. et al. , Plasma metabolic profiling and novel metabolite biomarkers for diagnosing prostate cancer RSC Adv. 2017 7 48 30060 30069 10.1039/C7RA04337F 

    상세보기

38. Sun H. Zhang A. Wang X. Potential role of metabolomic approaches for Chinese medicine syndromes and herbal medicine Phytother. Res. 2012 26 10 1466 1471 22422429 

39. Zhang A. Sun H. Wang P. et al. , Salivary proteomics in biomedical research Clin. Chim. Acta 2013 415 261 265 10.1016/j.cca.2012.11.001 23146870 

    상세보기

40. Zhang H. L. Zhang A. H. Zhou X. H. et al. , High-throughput lipidomics reveal mirabilite regulating lipid metabolism as anticancer therapeutics RSC Adv. 2018 8 62 35600 35610 10.1039/C8RA06190D 

    상세보기

41. Sun H. Zhang A. Yang L. et al. , High-throughput chinmedomics strategy for discovering the quality-markers and potential targets for Yinchenhao decoction Phytomedicine 2019 54 328 338 10.1016/j.phymed.2018.04.015 30340940 

    상세보기

42. Fang H. Zhang A. H. Sun H. et al. , High-throughput metabolomics screen coupled with multivariate statistical analysis identifies therapeutic targets in alcoholic liver disease rats using liquid chromatography-mass spectrometry J. Chromatogr. B: Anal. Technol. Biomed. Life Sci. 2019 1109 112 120 10.1016/j.jchromb.2019.01.017 30743140 

    상세보기

43. Sun H. Zhang A. Yan G. et al. , Metabolomic analysis of key regulatory metabolites in hepatitis C virus–infected tree shrews Mol. Cell. Proteomics 2013 12 3 710 719 10.1074/mcp.M112.019141 23264353 

    상세보기

44. Xiong H. Zhang A. H. Zhao Q. Q. et al. , Discovery and screening quality-marker ingredients of Panax quinquefolius using chinmedomics approach Phytomedicine 2019 152928 10.1016/j.phymed.2019.152928 31451286 

    상세보기

45. Zhang A. Wang H. Sun H. et al. , Metabolomics strategy reveals therapeutical assessment of limonin on nonbacterial prostatitis Food Funct. 2015 6 11 3540 3549 10.1039/C5FO00489F 26302114 

    

46. Nan Y. Zhou X. Liu Q. et al. , Serum metabolomics strategy for understanding pharmacological effects of ShenQi pill acting on kidney yang deficiency syndrome J. Chromatogr. B: Anal. Technol. Biomed. Life Sci. 2016 1026 217 226 10.1016/j.jchromb.2015.12.004 26747643 

    상세보기

47. Zhang A. Sun H. Wang X. Emerging role and recent applications of metabolomics biomarkers in obesity disease research RSC Adv. 2017 7 25 14966 14973 10.1039/C6RA28715H 

    상세보기

48. Xie J. Zhang A. H. Qiu S. Identification of the perturbed metabolic pathways associating with prostate cancer cells and anticancer affects of obacunone J. Proteomics 2019 206 103447 10.1016/j.jprot.2019.103447 31326558 

    상세보기

49. Zhang A. Sun H. Wang P. et al. , Future perspectives of personalized medicine in traditional Chinese medicine: a systems biology approach Complement. Ther. Med. 2012 20 1–2 93 99 10.1016/j.ctim.2011.10.007 22305254 

    상세보기

50. Zhang A. Sun H. Wang X. Potentiating therapeutic effects by enhancing synergism based on active constituents from traditional medicine Phytother. Res. 2014 28 4 526 533 10.1002/ptr.5032 23913598 

    상세보기

51. Sun H. Zhang H. L. Zhang A. H. et al. , Network pharmacology combined with functional metabolomics discover bile acid metabolism as a promising target for mirabilite against colorectal cancer RSC Adv. 2018 8 30061 30070 10.1039/C8RA04886J 

    상세보기

52. Zhang Y. Liu P. Li Y. et al. , Exploration of metabolite signatures using high-throughput mass spectrometry coupled with multivariate data analysis RSC Adv. 2017 7 6780 6787 10.1039/C6RA27461G 

    상세보기

53. Liang Q. Liu H. Li X. et al. , High-throughput metabolomics analysis discovers salivary biomarkers for predicting mild cognitive impairment and Alzheimer's disease RSC Adv. 2016 6 75499 75504 10.1039/C6RA16802G 

    상세보기

54. Wang L. Dong H. Zhang A. H. et al. , Exploring the detoxification effects and mechanism of Caowu in prescription using liquid chromatography-high-resolution mass spectrometry-based metabolomics Open Journal of Proteomics and Genomics 2018 3 1 011 023 

55. Zhang A. H. Sun H. Yan G. L. et al. , Chinmedomics: A Powerful Approach Integrating Metabolomics with Serum Pharmacochemistry to Evaluate the Efficacy of Traditional Chinese Medicine Engineering 2019 5 60 68 10.1016/j.eng.2018.11.008 

    상세보기

56. Sun H. Zhang A. H. Liu S. B. et al. , Cell metabolomics identify regulatory pathways and targets of magnoline against prostate cancer J. Chromatogr. B: Anal. Technol. Biomed. Life Sci. 2018 1102–1103 143 151 10.1016/j.jchromb.2018.10.017 30391728 

    상세보기

57. Feng C. C. Zhang A. H. Miao J. H. et al. , Recent advances in understanding cross-talk between Bile Acids and Gut Microbiota Open Journal of Proteomics and Genomics 2018 3 1 024 034 

58. Wang X. J. Ren J. L. Zhang A. H. et al. , Novel applications of mass spectrometry-based metabolomics in herbal medicines and its active ingredients: Current evidence Mass Spectrom. Rev. 2019 38 4–5 380 402 10.1002/mas.21589 30817039 

    상세보기

59. Cao H. Zhang A. Zhang H. et al. , The application of metabolomics in traditional Chinese medicine opens up a dialogue between Chinese and Western medicine Phytother. Res. 2015 29 2 159 166 10.1002/ptr.5240 25331169 

    상세보기

60. Zhang H. Zhang A. Miao J. et al. , Targeting regulation of tryptophan metabolism for colorectal cancer therapy: a systematic review RSC Adv. 2019 9 3072 3080 10.1039/C8RA08520J 

    상세보기

61. Zhang A. Sun H. Qiu S. et al. , NMR-based metabolomics coupled with pattern recognition methods in biomarker discovery and disease diagnosis Magn. Reson. Chem. 2013 51 9 549 556 10.1002/mrc.3985 23828598 

    상세보기

62. Liu X. Zhang A. Fang H. et al. , Serum metabolomics strategy for understanding the therapeutic effects of Yin-Chen-Hao-Tang against Yanghuang syndrome RSC Adv. 2018 8 7403 7413 10.1039/C7RA11048K 

    상세보기

63. Fang H. Zhang A. Yu J. et al. , Insight into the metabolic mechanism of scoparone on biomarkers for inhibiting Yanghuang syndrome Sci. Rep. 2016 6 37519 10.1038/srep37519 27869223 

    상세보기

64. Zhang A. Sun H. Yan G. et al. , Mass spectrometry-based metabolomics: applications to biomarker and metabolic pathway research Biomed. Chromatogr. 2016 30 1 7 12 10.1002/bmc.3453 25739660 

    상세보기

65. Zhang A. Sun H. Han Y. et al. , Exploratory urinary metabolic biomarkers and pathways using UPLC-Q-TOF-HDMS coupled with pattern recognition approach Analyst 2012 137 18 4200 4208 10.1039/C2AN35780A 22852134 

    상세보기

66. Li X. Zhang A. Sun H. et al. , Metabolic characterization and pathway analysis of berberine protects against prostate cancer Oncotarget 2017 8 65022 65041 29029409 

67. Zhang A. Sun H. Yan G. et al. , Metabolomics in diagnosis and biomarker discovery of colorectal cancer Cancer Lett. 2014 345 1 17 20 10.1016/j.canlet.2013.11.011 24333717 

    상세보기

68. Chu H. Zhang A. Han Y. et al. , Metabolomics approach to explore the effects of Kai-Xin-San on Alzheimer's disease using UPLC/ESI-Q-TOF mass spectrometry J. Chromatogr. B: Anal. Technol. Biomed. Life Sci. 2016 1015 50 61 10.1016/j.jchromb.2016.02.007 26896572 

    상세보기

69. Sun H. Li X. Zhang A. et al. , Exploring potential biomarkers of coronary heart disease treated by Jing Zhi Guan Xin Pian using high-throughput metabolomics RSC Adv. 2019 9 20 11420 11432 10.1039/C8RA10557J 

    상세보기

70. Zhang A. Sun H. Yan G. et al. , Serum proteomics in biomedical research: a systematic review Appl. Biochem. Biotechnol. 2013 170 4 774 786 10.1007/s12010-013-0238-7 23609910 

    상세보기

71. Sun H. Wang H. Zhang A. et al. , Berberine ameliorates nonbacterial prostatitis via multi-target metabolic network regulation OMICS A J. Integr. Biol. 2015 19 3 186 195 10.1089/omi.2014.0112 25588034 

    상세보기

72. Li X. Han Y. Zhang A. et al. , Mechanistic and Therapeutic Advances in Colon Cancer: A Systematic Review Open Journal of Proteomics and Genomics 2019 4 1 001 012 10.1385/ABAB:125:1:001 

    상세보기

73. Yan G. Zhang A. Sun H. et al. , An effective method for determining the ingredients of S huanghuanglian formula in blood samples using high-resolution LC-MS coupled with background subtraction and a multiple data processing approach J. Sep. Sci. 2013 36 19 3191 3199 23913749 

74. Zhang A. Sun H. Yan G. et al. , Metabolomics for biomarker discovery: moving to the clinic BioMed Res. Int. 2015 2015 354671 26090402 

75. Zhang A. Sun H. Qiu S. et al. , Metabolomics in noninvasive breast cancer Clin. Chim. Acta 2013 424 3 7 10.1016/j.cca.2013.05.003 23669185 

    상세보기

76. Sun H. Wang M. Zhang A. et al. , UPLC-Q-TOF-HDMS Analysis of Constituents in the Root of Two Kinds of Aconitum Using a Metabolomics Approach Phytochem. Anal. 2013 24 3 263 276 10.1002/pca.2407 23225552 

    상세보기

77. Zhang A. Sun H. Wang X. Potentiating therapeutic effects by enhancing synergism based on active constituents from traditional medicine Phytother. Res. 2014 28 4 526 533 10.1002/ptr.5032 23913598 

    상세보기

78. Zhao Y. Lv H. Qiu S. et al. , Plasma metabolic profiling and novel metabolite biomarkers for diagnosing prostate cancer RSC Adv. 2017 7 48 30060 30069 10.1039/C7RA04337F 

    상세보기

79. Zhang A. Qiu S. Xu H. et al. , Metabolomics in diabetes Clin. Chim. Acta 2014 429 106 110 10.1016/j.cca.2013.11.037 24321733 

    상세보기

80. Zhang A. Yan G. Sun H. et al. , Deciphering the biological effects of acupuncture treatment modulating multiple metabolism pathways Sci. Rep. 2016 6 19942 10.1038/srep19942 26879284 

    상세보기

81. Wang X. Sun H. Zhang A. et al. , Ultra-performance liquid chromatography coupled to mass spectrometry as a sensitive and powerful technology for metabolomic studies J. Sep. Sci. 2011 34 24 3451 3459 10.1002/jssc.201100333 21826791 

    상세보기

82. Wang X. Sun H. Zhang A. et al. , Potential role of metabolomics apporoaches in the area of traditional Chinese medicine: as pillars of the bridge between Chinese and Western medicine J. Pharm. Biomed. Anal. 2011 55 5 859 868 10.1016/j.jpba.2011.01.042 21353755 

    상세보기

83. Zhang A. Sun H. Wang Z. et al. , Metabolomics: towards understanding traditional Chinese medicine Planta Med. 2010 76 17 2026 2035 10.1055/s-0030-1250542 21058239 

    상세보기

84. Yuan L. Wang T. Zhang Y. et al. , An HBV-tolerant immunocompetent model that effectively simulates chronic hepatitis B virusinfection in mice Exp. Anim. 2016 65 4 373 382 10.1538/expanim.16-0013 27264142 

    상세보기

85. Ye L. Yu H. Li C. et al. , Adeno-Associated Virus Vector Mediated Delivery of the HBV Genome Induces Chronic Hepatitis B Virus Infection and Liver Fibrosis in Mice PLoS One 2015 10 6 e0130052 10.1371/journal.pone.0130052 26075890 

    상세보기

86. Wieland S. F. The chimpanzee model for hepatitis B virus infection Cold Spring Harbor Perspect. Med. 2015 5 6 a021469 10.1101/cshperspect.a021469 26033082 

    상세보기

87. Roggendorf M. Kosinska A. D. Liu J. et al. , The Woodchuck, a Nonprimate Model for Immunopathogenesis and Therapeutic Immunomodulation in Chronic Hepatitis B Virus Infection Cold Spring Harbor Perspect. Med. 2015 5 12 a021451 10.1101/cshperspect.a021451 26511761 

    

88. Funk A. Mhamdi M. Will H. et al. , Avian hepatitis B viruses: molecular and cellular biology, phylogenesis, and host tropism World J. Gastroenterol. 2007 13 1 91 103 10.3748/wjg.v13.i1.91 17206758 

    상세보기

89. Chang Y. Li H. Ren H. et al. , Misclassification of chronic hepatitis B natural history phase: Insight from new ALT, AST, AKP, and GGT reference intervals in Chinese children Clin. Chim. Acta 2019 489 61 67 10.1016/j.cca.2018.11.034 30503274 

    상세보기

90. Wu X. Z. Chen D. Zhao L. S. et al. , Early diagnosis of bacterial and fungal infection in chronic cholestatic hepatitis B World J. Gastroenterol. 2004 10 15 2228 2231 10.3748/wjg.v10.i15.2228 15259071 

    상세보기

91. Wu Y. M. Xu X. F. Wu W. L. et al. , Correlation between levels of liver fibrosis and liver fibrosis biochemical parameters of advanced schistosomiasis patients Zhongguo Xuexichongbing Fangzhi Zazhi 2014 26 1 65 67 24800570 

92. de Souza-Cruz S. Victória M. B. Tarragô A. M. et al. , Liver and blood cytokine microenvironment in HCV patients is associated to liver fibrosis score: a proinflammatory cytokine ensemble orchestrated by TNF and tuned by IL-10 BMC Microbiol. 2016 16 3 10.1186/s12866-015-0610-6 26742960 

    상세보기

93. Zeng D. W. Liu Y. R. Dong J. et al. , Serum HBsAg and HBeAg levels are associated with liver pathological stages in the immune clearance phase of hepatitis B virus chronic infection Mol. Med. Rep. 2015 11 5 3465 3472 10.3892/mmr.2015.3207 25592612 

    상세보기

94. Chen C. Y. Crowther C. Kew M. C. et al. , A valine to phenylalanine mutation in the precore region of hepatitis B virus causes intracellular retention and impaired secretion of HBe-antigen Hepatol. Res. 2008 38 6 580 592 10.1111/j.1872-034X.2007.00315.x 18201182 

    상세보기

95. Shan C. Xu F. Zhang S. et al. , Hepatitis B virus X protein promotes liver cell proliferation via a positive cascade loop involving arachidonic acid metabolism and p-ERK1/2 Cell Res. 2010 20 5 563 575 10.1038/cr.2010.49 20386571 

    상세보기

96. Desai R. Patel U. Sharma S. et al. , Association Between Hepatitis B Infection and Pancreatic Cancer: A Population-Based Analysis in the United States Pancreas 2018 47 7 849 855 10.1097/MPA.0000000000001095 29939908 

    상세보기

97. Wang X. J. Hu W. Zhang T. Y. et al. , Irbesartan, an FDA approved drug for hypertension and diabetic nephropathy, is a potent inhibitor for hepatitis B virus entry by disturbing Na(+)-dependent taurocholate cotransporting polypeptide activity Antiviral Res. 2015 120 140 146 10.1016/j.antiviral.2015.06.007 26086883 

    상세보기

98. Lin X. Ma Z. M. Yao X. et al. , Substitution of proline 306 in the reverse transcriptase domain of hepatitis B virus regulates replication J. Gen. Virol. 2005 86 1 85 90 10.1099/vir.0.80581-0 15604434 

    상세보기

99. Böttcher B. Nassal M. Structure of Mutant Hepatitis B Core Protein Capsids with Premature Secretion Phenotype J. Mol. Biol. 2018 430 24 4941 4954 10.1016/j.jmb.2018.10.018 30539760 

    상세보기

100. Zhang A. Sun H. Wang X. Urinary metabolic profiling of rat models revealed protective function of scoparone against alcohol induced hepatotoxicity Sci. Rep. 2014 4 6768 10.1038/srep06768 25341677 

     상세보기

101. Zhang A. Ma Z. Sun H. et al. , High-Throughput Metabolomics Evaluate the Efficacy of Total Lignans From Acanthophanax Senticosus Stem Against Ovariectomized Osteoporosis Rat Front. Pharmacol. 2019 10 553 10.3389/fphar.2019.00553 31191306 

     상세보기

102. Zhang A. Sun H. Yan G. et al. , Mass spectrometry-based metabolomics: applications to biomarker and metabolic pathway research Biomed. Chromatogr. 2016 30 1 7 12 10.1002/bmc.3453 25739660 

     상세보기

103. Wang X. Gao X. Zhang A. et al. , High-throughput metabolomics for evaluating the efficacy and discovering the metabolic mechanism of Luozhen capsules from the excessive liver-fire syndrome of hypertension RSC Adv. 2019 9 55 32141 32153 10.1039/C9RA06622E 

     상세보기

104. Zhang A. Sun H. Wang P. et al. , Modern analytical techniques in metabolomics analysis Analyst 2012 137 2 293 300 10.1039/C1AN15605E 22102985 

     상세보기

105. Zhang A. H. Yu J. B. Sun H. et al. , Identifying quality-markers from Shengmai San protects against transgenic mouse model of Alzheimer's disease using chinmedomics approach Phytomedicine 2018 45 84 92 10.1016/j.phymed.2018.04.004 29685366 

     상세보기

106. Zhang A. Sun H. Yan G. et al. , Metabolomics study of type 2 diabetes using ultra-performance LC-ESI/quadrupole-TOF high-definition MS coupled with pattern recognition methods J. Physiol. Biochem. 2014 70 1 117 128 10.1007/s13105-013-0286-z 23975652 

     상세보기

107. Zhang A. Sun H. Qiu S. et al. , Metabolomics insights into pathophysiological mechanisms of nephrology Int. Urol. Nephrol. 2014 46 5 1025 1030 10.1007/s11255-013-0600-2 24217804 

     상세보기

108. Zhang A. Sun H. Yan G. et al. , Metabolomics in diagnosis and biomarker discovery of colorectal cancer Cancer Lett. 2014 345 1 17 20 10.1016/j.canlet.2013.11.011 24333717 

     상세보기

109. Dong H. Zhang A. Sun H. et al. , Ingenuity pathways analysis of urine metabolomics phenotypes toxicity of Chuanwu in Wistar rats by UPLC-Q-TOF-HDMS coupled with pattern recognition methods Mol. BioSyst. 2012 8 4 1206 1221 10.1039/C1MB05366C 22282765 

     상세보기

110. Zhang A. Sun H. Xu H. et al. , Cell metabolomics OMICS A J. Integr. Biol. 2013 17 10 495 501 10.1089/omi.2012.0090 23988149 

     상세보기

111. Wang X. Zhang A. Zhou X. et al. , An integrated chinmedomics strategy for discovery of effective constituents from traditional herbal medicine Sci. Rep. 2016 6 18997 10.1038/srep18997 26750403 

     상세보기

112. Li Y. F. Qiu S. Gao L. J. et al. , Metabolomic estimation of the diagnosis of hepatocellular carcinoma based on ultrahigh performance liquid chromatography coupled with time-of-flight mass spectrometry RSC Adv. 2018 8 17 9375 9382 10.1039/C7RA13616A 

     상세보기

113. Wang X. Li J. Zhang A. H. Urine metabolic phenotypes analysis of extrahepatic cholangiocarcinoma disease using ultra-high performance liquid chromatography-mass spectrometry RSC Adv. 2016 6 67 63049 63057 10.1039/C6RA09430A 

     상세보기

114. Qiu S. Zhang A. Zhang T. et al. , Dissect new mechanistic insights for geniposide efficacy on the hepatoprotection using multiomics approach Oncotarget 2017 8 65 108760 108770 29312565 

115. Wang H. Yan G. Zhang A. et al. , Rapid discovery and global characterization of chemical constituents and rats metabolites of Phellodendri amurensis cortex by ultra-performance liquid chromatography-electrospray ionization/quadrupole-time-of-flight mass spectrometry coupled with pattern recognition approach Analyst 2013 138 11 3303 3312 10.1039/C3AN36902A 23608925 

     상세보기